Improving the global management of the neurogenic bladder patient: Part I. The complexity of patients

Current Medical Research and Opinion

Volumn 22, Issue 2, 2006, Pages 359-365

  Denys, Pierre ^a   Corcos, Jacques ^b   Everaert, Karel ^c   Chartier Kastler, Emmanuel ^d   Fowler, Clare ^e   Kalsi, Vinay ^e   Nitti, Victor ^f   Schulte Baukloh, Heinrich ^g   Schurch, Brigitte ^h  

^a RAYMOND POINCARÉ HOSPITAL   (France)

^b MCGILL UNIVERSITY   (Canada)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^f NEW YORK UNIVERSITY   (United States)

^g St Hedwig Hospital   (Germany)

^h BALGRIST UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Botulinum toxin; Global patient management; Multidisciplinary; Neurogenic urinary incontinence; Neurological disease

Indexed keywords

BOTULINUM TOXIN A; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; OXYBUTYNIN;

CLINICAL PRACTICE; COMMUNITY CARE; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG BIOAVAILABILITY; DYSTONIA; HEALTH CARE ORGANIZATION; HUMAN; KIDNEY FAILURE; MEDICAL ASSESSMENT; MEDICAL SPECIALIST; NEUROGENIC BLADDER; OVERACTIVE BLADDER; PAIN; PHYSICIAN; PRACTICE GUIDELINE; PROSTATE HYPERTROPHY; PUBLICATION; REVIEW; SEXUAL DYSFUNCTION; SPASTICITY; SPINAL CORD INJURY; URINARY TRACT DISEASE; URINARY TRACT INFECTION; ARTICLE; EUROPE; HEALTH CARE QUALITY; PATHOPHYSIOLOGY; STANDARD; URINE INCONTINENCE;

EUROPE; HUMANS; PRACTICE GUIDELINES; QUALITY OF HEALTH CARE; URINARY BLADDER, NEUROGENIC; URINARY INCONTINENCE;

EID: 33645749642     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079906X89702     Document Type: Review

References (41)

1. Fingerman JS, Finkelstein LH. The overactive bladder in multiple sclerosis. J Am Osteopath Assoc 2000;100(Suppl 3): S9-S12
2. Litwiller SE, Frohman EM, Zimmern PE. Multiple sclerosis and the urologist. J Urol 1999;161:743-57
3. Giannantoni A, Scivoletto G, Di Stasi SM, et al. Lower urinary tract dysfunction and disability status in patients with multiple sclerosis. Arch Phys Med Rehabil 1999;80:437-41
4. Kalsi V, Fowler CJ. Therapy insight: bladder dysfunction associated with multiple sclerosis. Nature Clin Pract Urol 2005;2:492-501
5. Betts CD, D'Mellow MT, Fowler CJ. Urinary symptoms and the neurological features of bladder dysfunction in multiple sclerosis. J Neurol Neurosurg Psychiatry 1993;56:245-50
6. Awad SA, Gajewski JB, Sogbein SK, et al. Relationship between neurological and urological status in patients with multiple sclerosis. J Urol 1984;132:499-502
7. Morgan M, Goodson J, Barnett G. Long-term changes in compliance with clinical guidelines through computer-based reminders. Proc AMIA Symp 1998; Harvard Ed, 1-5
8. Lomas J, Anderson GM, Domnik-Pierre K, et al. Do practice guidelines guide practice? The effect of a consensus statement on the practice of physicians. New Engl J Med 1989;321:1306-11
9. Zielstorff RD. Online practice guidelines: issues, obstacles, and future prospects. J Am Med Inform Assoc 1998;5:227-36
10. Zeilig G, Dolev M, Weingarden H, et al. Long-term morbidity and mortality after spinal cord injury: 50 years of follow-up. Spinal Cord 2000;38:563-6
11. Hackler RH. A 25-year prospective mortality study in the spinal cord injured patient: comparison with the long-term living paraplegic. J Urol 1977;117:486-8
12. Frankel HL, Coll JR, Charlifue SW, et al. Long-term survival in spinal cord injury: a fifty year investigation. Spinal Cord 1998;36:266-74
13. Lawrenson R, Wyndaele JJ, Vlachonikolis I, et al. Renal failure in patients with neurogenic lower urinary tract dysfunction. Neuroepidemiology 2001;20:138-43
14. Yuruktumen A, Karcioglu O, Topacoglu H, et al. Acute renal failure associated with dysfunctioning detrusor muscle in multiple sclerosis. Adv Ther 2004;21:343-7
15. Weld KJ, Dmochowski RR. Effect of bladder management on urological complications in spinal cord injured patients. J Urol 2000;163:768-72
16. Yavuzer G, Gok H, Tuncer S, et al. Compliance with bladder management in spinal cord injury patients. Spinal Cord 2000;38:762-5
17. Evans D. Lifestyle solutions for men with continence problems. Nurs Times 2005;101:61-2, 64
18. Horrocks S, Somerset M, Stoddart H, et al. What prevents older people from seeking treatment for urinary incontinence? A qualitative exploration of barriers to the use of community continence services. Fam Pract 2004;21:689-96
19. Shaw C, Tansey R, Jackson C, et al. Barriers to help seeking in people with urinary symptoms. Fam Pract 2001;18:48-52
20. European Association of Urology. Guidelines on incontinence [Adapted by the EAU Working Group 'Incontinence', from Clinical Guidelines for the Management of Incontinence]. Plymouth (UK): Health Publication Ltd) 1999
21. Wyndaele JJ, Castro D, Madersbacher H, et al. Neurologic urinary and faecal incontinence. In Abrams P, Cardozo L, Khuory S et al. (Eds): Incontinence, Vol. 2, Chapter 17: Management. Plymouth (UK): Health Publication Ltd; 2005. pp. 1059-162
22. Stohrer M, Castro-Diaz D, Chartier-Kastler E, et al. Guidelines on neurogenic lower urinary tract dysfunction. European Association of Urology: 2003
23. Anderson K-E, Appell R, Cardozo L, et al. Chapter 14: pharmacological treatment of urinary incontinence. In: Incontinence, vol 2: management. Plymouth (UK): Health Publication Ltd; 2005. p. 809-54
24. Oshima S, Kirschner KL, Heinemann A, et al. Assessing the knowledge of future internists and gynecologists in caring for a woman with tetraplegia. Arch Phys Med Rehabil 1998;79:1270-9
25. Hawker KS, Frohman EM. Bladder, bowel, and sexual dysfunction in multiple sclerosis. Curr Treat Options Neurol 2001;3:207-14
26. Crayton H, Heyman RA, Rossman HS. A multimodal approach to managing the symptoms of multiple sclerosis. Neurology 2004;63(Suppl 5):S12-S18
27. Andersson KE, Pehrson R. CNS involvement in overactive bladder: pathophysiology and opportunities for pharmacological intervention. Drugs 2003;63:2595-611
28. Watanabe T, Perkash I, Constantinou CE. Modulation of detrusor contraction strength and micturition characteristics by intrathecal baclofen in anesthetized rats. J Urol 1997;157:2361-5
29. Aranda B, Cramer P. Effects of apomorphine and L-dopa on the parkinsonian bladder. Neurourol Urodyn 1993;12:203-9
30. Uchiyama T, Sakakibara R, Hattori T, et al. Short-term effect of a single levodopa dose on micturition disturbance in Parkinson's disease patients with the wearing-off phenomenon. Mov Disord 2003;18:573-8
31. Seif C, Herzog J, van der Horst C, et al. Effect of subthalamic deep brain stimulation on the function of the urinary bladder. Ann Neurol 2004;55:118-20
32. Dalmose AL, Bjarkam CR, Sorensen JC, et al. Effects of high frequency deep brain stimulation on urine storage and voiding function in conscious minipigs. Neurourol Urodyn 2004;23:265-72
33. Metz LM, McGuinness SD, Harris C. Urinary tract infections may trigger relapse in multiple sclerosis. Axone 1998;19:67-70
34. Pesce F, Rubilotta E, D'Amico A, et al. Long-term anticholinergic therapy: duration and causes of discontinuation. Presented at ICS, 2003, Florence
35. Schurch B, de Seze M, Denys P, et al. Botulinum toxin is a safe and effective treatment for neurogenic urinary incontinence: results from a single-treatment, randomized, placebo-controlled 6-month study. J Urol 2005;174:196-200
36. Reitz A, Stohrer M, Kramer G, et al. European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity. Eur Urol 2004;45:510-5
37. Stohrer M, Schurch B, Kramer G, et al. Botulinum-A toxin in the treatment of detrusor hyperreflexia in spinal cord injured patients: a new alternative to medical and surgical procedures? Neurourol Urodyn 1999;18:401-2
38. Grosse J, Kramer G, Stohrer M. Success of repeat detrusor injections of botulinum A toxin in patient with severe neurogenic detrusor overactivity and incontinence. Eur Urol 2005;47:653-9
39. Bycroft J, Hamid R, Bywater H, et al. Variation in urological practice amongst spinal injuries units in the UK and Eire. Neurourol Urodyn 2004;23:252-6 [Discussion 7]
40. Jamil F. Towards a catheter free status in neurogenic bladder dysfunction: a review of bladder management options in spinal cord injury (SCI). Spinal Cord 2001;39:355-61
41. Yavuzer G, Gok, H, Tuncer S, et al. Compliance with bladder management in spinal cord injury patients. Spinal Cord 2000;38:762-5